Cells were then incubated either in the presence or absence of anti-IgM antibody. Flow cytometry analysis of cells cultured for 36 h in the absence of anti-IgM revealed no major difference in BAFF-R expression comparing the three BM B-cell subsets (Fig. 5), with IgM+ CD93+ CD23– BAFF-R– B cells becoming BAFF-R+ as a consequence of spontaneously occurring development. Also, the three splenic B-cell populations did not show major differences in BAFF-R expression after being cultured for 36 h in the absence SCH727965 mouse of anti-IgM (Fig. 5). However, when incubated in
the presence of anti-IgM antibody, induction of BAFF-R expression was inhibited on PI-negative gated IgM+ CD93+ CD23– BAFF-R− immature BM B cells and down-modulated on the other two immature BM B-cell subtypes analyzed (also PI-negative gated; Fig. 5). Transitional
T1 B cells (PI-negative gated) also showed down-modulation of the BAFF-R Obeticholic Acid purchase upon BCR cross-linking (Fig. 5). In marked contrast, follicular B cells showed upon BCR cross-linking a strong up-regulation of BAFF-R expression (Fig. 5). About 60% of the transitional T2/3 B cells down-modulated BAFF-R expression upon incubation with anti-IgM, whereas 40% up-regulated BAFF-R expression (Fig. 5). This finding suggests that part of the T2/3 population is already more mature and therefore like the follicular B cells show up-regulation of BAFF-R upon BCR cross-linking. Methane monooxygenase Overall, these findings show that the induction of apoptosis by BCR cross-linking on immature B cells is preceded by BAFF-R down-modulation,
whereas the proliferation of mature B cells upon BCR cross-linking is accompanied by BAFF-R up-regulation. Using a similar approach as for mouse cells, we generated a mAb against human BAFF-R. To test the expression of BAFF-R on human mature B cells, cord blood as well as adult peripheral blood samples were analyzed by flow cytometry. As for mouse B cells, surface expression of BAFF-R could be detected on all circulating CD19+ B cells but not on any other cell type in the peripheral blood (data not shown). To investigate the expression of BAFF-R on B-cell precursors, BM of young children was analyzed. Based on the surface expression of CD19, IgM and CD10, human B-cell developmental intermediates can be subdivided into early pre/pro-B (CD19+ IgM– CD10+), immature B (CD19+ IgM+ CD10+) and mature re-circulating B (CD19+ IgM+ CD10–) (Fig. 6A). As for mouse BM, human pre/pro-B cells were negative for surface BAFF-R expression (Fig. 6B), while matureB cells displayed high levels (Fig. 6B). Within the immature B-cell compartment, an intermediate expression level of BAFF-R could be detected, with bi-modal expression seen as for the mouse counterpart. Therefore, in this regard BAFF-R expression during human and mouse B-cell development seems to be similar.